The effects of the degree of mobility reduction and prespecified risk factors on venous thromboembolism rates in acutely ill medical patients in the EXCLAIM study

被引：2
|
作者：
Yusen, Roger D. [1 ]
Hull, Russell D. [2 ]
Schellong, Sebastian M. [3 ]
Tapson, Victor F. [4 ]
Monreal, Manuel [5 ]
Samama, Meyer-Michel [6 ]
Turpie, Alexander G. G. [7 ]
机构：
[1] Washington Univ, St Louis, MO USA
[2] Univ Calgary, Foothills Hosp, Calgary, AB, Canada
[3] Hosp Carl Gustav Carus, Dresden, Germany
[4] Duke Univ, Med Ctr, Durham, NC USA
[5] Hosp German Trias Pujol, Barcelona, Spain
[6] Univ Hosp, Hotel Dieu, Paris, France
[7] McMaster Univ, HHSC McMaster Clin, Hamilton, ON, Canada
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.1862.1862
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1862
引用
收藏
页码：551A / 551A
页数：1
相关论文
共 50 条
  • [31] Risk Factors for Venous Thromboembolism in Critically Ill Patients
    Panyavachiraporn, N.
    Viarasilpa, T.
    Jordan, J.
    Marashi, S. M.
    Rubinfeld, I.
    Harn, M. V.
    Kowalski, R. G.
    Mayer, S. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [32] Rivaroxaban Compared with Enoxaparin for the Prevention of Venous Thromboembolism In Acutely Ill Medical Patients: MAGELLAN Study Methodology
    Cohen, Alexander Thomas
    Spiro, Theodore Erich
    Buller, Harry Roger
    Haskell, Lloyd
    Hu, Da-Yi
    Hull, Russell
    Mebazaa, Alexandre
    Merli, Geno
    Schellong, Sebastian
    Spyropoulos, Alexander
    Tapson, Victor
    BLOOD, 2010, 116 (21) : 1364 - 1364
  • [33] Venous thromboembolism prophylaxis and risk in the inpatient and outpatient continuum of care among acutely ill medical patients in the US
    Amin, Alpesh
    Neuman, W. Richey
    Lingohr-Smith, Melissa
    Menges, Brandy
    Lin, Jay
    PHARMACOTHERAPY, 2017, 37 (12): : E142 - E143
  • [34] Can fondaparinux safely prevent the occurrence of venous thromboembolism in acutely ill medical patients?
    Schulman, S
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2006, 3 (07): : 358 - 359
  • [35] Can fondaparinux safely prevent the occurrence of venous thromboembolism in acutely ill medical patients?
    Sam Schulman
    Nature Clinical Practice Cardiovascular Medicine, 2006, 3 : 358 - 359
  • [36] Thromboprophylaxis with dalteparin for the prevention of venous thromboembolism in acutely ill medical patients with respiratory failure
    Cohen, AT
    Leizorovicz, A
    Turpie, AG
    Olsson, CG
    Vaitkus, PT
    Goldhaber, SZ
    CHEST, 2003, 124 (04) : 132S - 133S
  • [37] Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada
    Kahn, Susan R.
    Panju, Akbar
    Geerts, William
    Pineo, Graham F.
    Desjardins, Louis
    Turpie, Alexander G. G.
    Glezer, Stanislav
    Thabane, Lehana
    Sebaldt, Rolf J.
    THROMBOSIS RESEARCH, 2007, 119 (02) : 145 - 155
  • [38] A multinational observational cohort study in acutely ill medical patients of practices in prevention of venous thromboembolism: Findings of the international medical prevention registry on venous thromboembolism (IMPROVE).
    Tapson, VF
    Decousus, H
    Piovella, F
    Zotz, RB
    Allegrone, J
    Anderson, FA
    BLOOD, 2003, 102 (11) : 321A - 321A
  • [39] Venous thromboembolism in critically ill patients: incidence and risk factors
    S Al-Qahtani
    Y Arabi
    A Aldawood
    Critical Care, 11 (Suppl 2):
  • [40] Risk factors for venous thromboembolism in hospitalized medical patients
    Rojnuckarin, P.
    Uaprasert, N.
    Buranasupkajorn, P.
    Siwamogsatham, S.
    Sutcharitchan, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 902 - 902
12345